Analyst Ratings

  • Home -
  • Analyst Ratings
Laidlaw Maintains Buy Rating on Aldeyra, Confident in Growth Despite FDA Shock

Laidlaw Maintains Buy Rating on Aldeyra, Confident in Growth Despite FDA Shock

Shares of Aldeyra Therapeutics (NASDAQ: ALDX), a $107 million market cap biotech company, continued to be unde...

TD Cowen Adjusts ExxonMobil Price Target to $125, Maintains Buy Rating

TD Cowen Adjusts ExxonMobil Price Target to $125, Maintains Buy Rating

NEW YORK (Investing.com) – Analysts at TD Cowen on Friday cut their price target on ExxonMobil (NYSE: XOM) sha...

RBC Capital sets Lumina Gold stock target at Cdn$1.50

RBC Capital sets Lumina Gold stock target at Cdn$1.50

On Tuesday, RBC Capital Markets initiated coverage on Lumina Gold Corp. (TSXV: LUM), assigning the stock an “O...

Life360 stock holds $55 target, Market Outperform rating

Life360 stock holds $55 target, Market Outperform rating

Investing.com - Life360 Inc. (NASDAQ: LIF) has maintained an Outperform rating with a $55.00 price target, acc...

Piper Sandler Maintains ABC Corp Stock at Overweight with $150 Price Target

Piper Sandler Maintains ABC Corp Stock at Overweight with $150 Price Target

Piper Sandler analysts on Friday maintained an Overweight rating with a $150 price target on ABC Corp (NASDAQ:...

Nomura Recommends Buy on XYZ Corp, Sets Price Target at JPY6,500

Nomura Recommends Buy on XYZ Corp, Sets Price Target at JPY6,500

On Monday, Nomura/Instinet initiated coverage on XYZ Corp (1234:JP) with a positive outlook, recommending Buy ...

Stay Connected
Tags